MCID: PPL001
MIFTS: 42

Papillary Adenoma

Categories: Cancer diseases, Endocrine diseases

Aliases & Classifications for Papillary Adenoma

MalaCards integrated aliases for Papillary Adenoma:

Name: Papillary Adenoma 12 15 72
Glandular Papilloma 12 72
Adenoma 44 72

Classifications:



External Ids:

Disease Ontology 12 DOID:3172
MeSH 44 D000236
NCIt 50 C79951
SNOMED-CT 68 86143001
UMLS 72 C0001430 C0205650 C3282896

Summaries for Papillary Adenoma

MalaCards based summary : Papillary Adenoma, also known as glandular papilloma, is related to renal adenoma and pregnancy adenoma. An important gene associated with Papillary Adenoma is KRT7 (Keratin 7), and among its related pathways/superpathways are Cytoskeletal Signaling and Keratinization. The drugs Linaclotide and Bromocriptine have been mentioned in the context of this disorder. Affiliated tissues include colon, pituitary and testes.

Related Diseases for Papillary Adenoma

Diseases related to Papillary Adenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1776)
# Related Disease Score Top Affiliating Genes
1 renal adenoma 34.0 KRT7 AMACR
2 pregnancy adenoma 33.9 KRT7 KRT5
3 middle ear adenoma 33.8 KRT7 KRT5
4 ceruminoma 33.3 KRT7 KRT5
5 lipoadenoma 32.3 KRT7 KRT5
6 secretory meningioma 31.5 VIM KRT7
7 chordoma 30.9 VIM KRT7
8 mucinous adenocarcinoma 30.9 NKX2-1 KRT7
9 urethral diverticulum 30.7 KRT7 AMACR
10 spindle cell sarcoma 30.7 VIM KRT7
11 adenoid cystic carcinoma 30.7 VIM KRT7 KRT5
12 small cell carcinoma 30.5 NKX2-1 KRT7
13 pulmonary sclerosing hemangioma 30.5 NKX2-1 KRT7
14 alveoli adenoma 30.4 NKX2-1 KRT7
15 hidradenoma 30.4 VIM KRT7
16 clear cell adenocarcinoma 30.4 KRT7 AMACR
17 fibrolamellar carcinoma 30.4 VIM KRT7
18 carcinosarcoma 30.4 VIM KRT7
19 cystic teratoma 30.4 NKX2-1 KRT7
20 mucinous cystadenocarcinoma 30.4 VIM KRT7
21 nephrogenic adenoma 30.3 KRT7 AMACR
22 endocervical adenocarcinoma 30.3 VIM KRT7
23 ovarian germ cell teratoma 30.3 NKX2-1 KRT7
24 teratoma 30.3 NKX2-1 KRT7
25 sclerosing hemangioma 30.2 NKX2-1 KRT7
26 papillary adenocarcinoma 30.2 VIM NKX2-1 KRT7
27 adenomatoid tumor 30.2 VIM KRT7
28 clear cell renal cell carcinoma 30.1 VIM OGG1 KRT7
29 metanephric adenoma 30.1 VIM KRT7 AMACR
30 oncocytoma 30.0 VIM KRT7 AMACR
31 large cell neuroendocrine carcinoma 30.0 NKX2-1 KRT7
32 lung benign neoplasm 30.0 NKX2-1 KRT7
33 eccrine sweat gland neoplasm 30.0 KRT7 KRT5
34 adenoid squamous cell carcinoma 30.0 VIM KRT7
35 nodular hidradenoma 30.0 VIM KRT7
36 cavernous hemangioma 30.0 VIM NKX2-1 KRT7
37 bronchiolo-alveolar adenocarcinoma 29.9 NKX2-1 KRT7
38 lymphoepithelioma-like carcinoma 29.9 KRT7 KRT5
39 benign mesothelioma 29.9 KRT7 KRT5
40 clear cell papillary renal cell carcinoma 29.9 KRT7 AMACR
41 epithelial predominant wilms' tumor 29.9 KRT7 AMACR
42 ovarian cystic teratoma 29.9 NKX2-1 KRT7
43 small cell carcinoma of the bladder 29.8 NKX2-1 KRT7
44 papillary carcinoma 29.8 NKX2-1 KRT7
45 intestinal perforation 29.8 NKX2-1 KRT7
46 adenosquamous carcinoma 29.8 NKX2-1 KRT7 KRT5
47 apocrine sweat gland neoplasm 29.7 KRT7 KRT5
48 horseshoe kidney 29.6 NKX2-1 KRT7
49 lung cancer susceptibility 3 29.5 OGG1 NKX2-1 NAPSA KRT7
50 odontoma 29.5 VIM KRT5

Graphical network of the top 20 diseases related to Papillary Adenoma:



Diseases related to Papillary Adenoma

Symptoms & Phenotypes for Papillary Adenoma

Drugs & Therapeutics for Papillary Adenoma

Drugs for Papillary Adenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 464)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Linaclotide Approved Phase 4 851199-59-2 65351
2
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
3
Scopolamine Approved, Investigational Phase 4 6533-68-2, 51-34-3 5184
4
Clarithromycin Approved Phase 4 81103-11-9 84029
5
Pantoprazole Approved Phase 4 102625-70-7 4679
6
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
7
Prucalopride Approved Phase 4 179474-81-8
8
Dexlansoprazole Approved, Investigational Phase 4 103577-45-3, 138530-94-6 9578005
9
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
10
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
11
Metronidazole Approved Phase 4 443-48-1 4173
12
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 441411 12560
13
Pasireotide Approved Phase 4 396091-73-9 9941444
14
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
15
Magnesium citrate Approved Phase 4 3344-18-1
16
Sodium citrate Approved, Investigational Phase 4 68-04-2
17
Bisacodyl Approved Phase 4 603-50-9
18
Glucagon Approved Phase 4 16941-32-5
19
Metformin Approved Phase 4 657-24-9 4091 14219
20
Alendronate Approved Phase 4 66376-36-1, 121268-17-5 2088
21
Liraglutide Approved Phase 4 204656-20-2 44147092
22
Zinc Approved, Investigational Phase 4 7440-66-6 32051
23
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
24
Cefdinir Approved Phase 4 91832-40-5 6915944
25
Sulfamethoxazole Approved Phase 4 723-46-6 5329
26
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
27
Cefazolin Approved Phase 4 25953-19-9 656510 33255
28
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
29
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
30
Acetaminophen Approved Phase 4 103-90-2 1983
31
Codeine Approved, Illicit Phase 4 76-57-3 5284371
32
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
33
Nitric Oxide Approved Phase 4 10102-43-9 145068
34
Sodium sulfate Approved, Vet_approved Phase 4 7757-82-6
35
Dyclonine Approved Phase 4 586-60-7 3180
36
Somatostatin Approved, Investigational Phase 4 38916-34-6, 51110-01-1 53481605
37
lanreotide Approved Phase 4 108736-35-2
38
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
39
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 54670067 5785
40
Lactitol Investigational Phase 4 585-86-4, 585-88-6 493591
41 Cholinergic Agents Phase 4
42 Muscarinic Antagonists Phase 4
43 Cholinergic Antagonists Phase 4
44 Anticonvulsants Phase 4
45 Bromides Phase 4
46 Butylscopolammonium Bromide Phase 4
47 Cytochrome P-450 CYP3A Inhibitors Phase 4
48 Purinergic P2Y Receptor Antagonists Phase 4
49 Purinergic P2 Receptor Antagonists Phase 4
50 Serotonin Receptor Agonists Phase 4

Interventional clinical trials:

(show top 50) (show all 901)
# Name Status NCT ID Phase Drugs
1 Efficacy and Cost-effectiveness of Colonoscopy vs. Combined Fecal Immunochemical Test-Sigmoidoscopy for the Detection of Advanced Colorectal Neoplasia (eCOLO-FITS): A Randomized Multicenter Trial Unknown status NCT01767870 Phase 4
2 Effects of Ilaprazole 20mg on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone Endoscopic Submucosal Dissection(ESD) for Gastric Adenoma or Early Gastric Cancer. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
3 Impact of Reinforced Education by Wechat and Short Message Service on the Quality of Bowel Preparation Unknown status NCT02832869 Phase 4
4 Does Hyoscine N-butylbromide Administered During Colonoscopy Increase the Polyp Detection Rate? a Randomized, Single Center, Double Blind, Placebo-controlled Study Unknown status NCT01609855 Phase 4 Hyoscine Butyl Bromide 20mg/2 ml i.v.;Saline 2 ml i.v.
5 Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism Unknown status NCT02127840 Phase 4 Synacthen infusion during adrenal venous sampling
6 Assessment of the Participation Rate and the Diagnostic Accuracy of a Colorectal Cancer Screening Program: CT Colonography Versus Flexible Sigmoidoscopy. Evaluation of a New Model Based on Telediagnosis Unknown status NCT01739608 Phase 4
7 Prophylactic Pancreatic Duct Stent Placement After Endoscopic Snare Papillectomy of Duodenal Major Papillary Tumors; Prospective, Randomized, Controlled Study Unknown status NCT01737463 Phase 4
8 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
9 Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy Unknown status NCT02781493 Phase 4 2 mg Prucalopride plus 2 L Polyethylene Glycol regimen;2 mg Placebo plus 2 L Polyethylene Glycol regimen
10 The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism Unknown status NCT00451672 Phase 4 bromocriptine
11 Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study Unknown status NCT03130452 Phase 4 Lansoprazole 30mg;Amoxicillin 1.0g Tab;Clarithromycin 500mg;Metronidazole 500 mg
12 Optimal Bowel Preparation Regimen for Patients With With a History of Colorectal Resection Before Colonoscopy Unknown status NCT02761317 Phase 4 standard preparation (2L PEG-ELS);low-volume preparation (10 mg bisacodyl plus 2L PEG-ELS);high-volume preparation (4L PEG-ELS)
13 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-protocol is Identical to Study No. 0519-10-TLV- Minors' Adjusted Version Unknown status NCT02354560 Phase 4 Erythromycin
14 Erythromycin as a Novel Therapy Against Familial Adenomatous Polyposis and Sporadic Colorectal Cancer by APC Nonsense Mutation Readthrough. Unknown status NCT02175914 Phase 4 Erythromycin
15 Clinical Effectiveness of Serum Chromogranin A (CgA) Levels on Diagnostic Relevance, Response After Surgical Resection and Recurrence of Pancreatic Endocrine Tumors (PET) Unknown status NCT02759718 Phase 4
16 Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLightTM Laser Photoselective Vaporization of the Prostate (PVP): A Randomized Double Blind Sexual and Urodynamic Assessment Unknown status NCT02749604 Phase 4
17 Can Involvement of Endoscopy Nurse Participation Increase Adenoma Detection Rate During Screening Colonoscopy?:A Prospective Multicenter Randomized Trial Completed NCT01124266 Phase 4
18 A SINGLE-ARM OPEN-LABEL INTERNATIONAL MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF SUNITINIB MALATE (SU011248, SUTENT (REGISTERED)) IN PATIENTS WITH PROGRESSIVE ADVANCED METASTATIC WELL-DIFFERENTIATED UNRESECTABLE PANCREATIC NEUROENDOCRINE TUMORS Completed NCT01525550 Phase 4 sunitinib
19 The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma Detection Rate During Screening Colonoscopy: A Randomized Controlled Pilot Trial Completed NCT03119168 Phase 4 Simethicone Solution
20 A Multi-centre, Randomised, Investigator-blinded Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate) Completed NCT01689792 Phase 4 MOVIPREP;CitraFleet
21 Comparative Efficacy of Water & Indigo Carmine vs Water or Air Method Completed NCT01607255 Phase 4 Indigo carmine
22 Octreotide Efficacy and Safety in First-line Acromegalic Patients Completed NCT00171886 Phase 4 Octreotide
23 A Multicenter, Single Arm, Proof of Concept Study to Investigate the Efficacy of an 8 Month Combination Therapy of Octreotide and Cabergoline in Acromegalic Patients Only Partially Responsive to Somatostatin Analog Monotherapy Completed NCT00376064 Phase 4 Octreotide acetate and cabergoline/Octrotide and Somavert
24 Effect of Gum Chewing on Bowel Cleansing Before Colonoscopy: A Prospective Randomized Study Completed NCT02507037 Phase 4 polyethylene glycol
25 Role of Glucagon in Outpatient Colonoscopy? A Prospective Double-Blind Randomized Controlled Trial Completed NCT02078726 Phase 4 Glucagon;Placebo
26 Does Surgical Debulking Of Pituitary Adenomas Improve Responsiveness To Octreotide LAR In The Treatment Of Acromegaly: An Investigator-Initiated Study Completed NCT01371643 Phase 4 Octreotide LAR
27 Green Light Laser (XPS) Photoselective Vaporization of the Prostate (PVP) Versus Bipolar Transurethral Vaporization (B.TUVP) of the Prostate for Treatment of Small to Moderate Sized Benign Prostate Hyperplasia: A Randomized Study Completed NCT02283684 Phase 4
28 Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment: Correlation With Disease Activity, Insulin Sensitivity and Secretion Parameters Completed NCT03080181 Phase 4 Pasireotide 0.6 MG/ML
29 Preoperative Octreotide Treatment of Patients With Growth Hormone Producing Pituitary Adenomas Completed NCT00521300 Phase 4 Octreotide
30 A Prospective Randomised Controlled Trial Comparing Cap-Assisted Colonoscopy Versus Standard Colonoscopy Completed NCT00930462 Phase 4
31 Evaluation of the Effects of Monopolar Transurethral Resection Versus Bipolar Transurethral Resection and Holmium Laser Enucleation of the Prostate on Urinary and Sexual Function; a Prospective Comparative Study. Completed NCT01810068 Phase 4
32 Efficacy of a Calcimimetic (Cinacalcet) in the Long Term Control of Patients With Primary Hyperparathyroidism Completed NCT02417389 Phase 4 cinacalcet;Alendronate
33 Tailored Bowel Preparation According to Bristol Stool Form Scale: a Prospective, Randomized, Controlled, Investigator-blinded, Multicenter Study Completed NCT02415569 Phase 4 Standard Bowel Prep (2L PEG-ELP);2L PEG-ELP and 10mg bisacodyl;Standard Bowel Prep (2L PEG-ELP)
34 Randomized Study Comparing Holmium Laser Enucleation of the Prostate (HOLEP) Versus Greenlight (XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) in the Management of Infravesical Obstruction Secondary to BPH Completed NCT01494337 Phase 4
35 Effects of Preoperative Administration of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection(EMR): Prospective, Randomized, Placebo-controlled, Comparative Study Completed NCT00844675 Phase 4 rabeprazole;placebo
36 A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly Completed NCT02060383 Phase 4 Pasireotide s.c.;Sitagliptin;Liraglutide;Insulin;Pasireotide LAR;Metformin
37 Long-term (up to 3 Years) Clinical and Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues: Open-labeled, Prospective, Parallel Group Study Recruiting NCT02427295 Phase 4 Sandostatin (Octreotide Acetate)
38 A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Impact of Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions Recruiting NCT03014687 Phase 4 Placebo;Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole
39 An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment Recruiting NCT01794793 Phase 4 Pasireotide;Cabergoline;Pasireotide
40 Minimizing Narcotic Analgesics After Thyroid or Parathyroid Surgery Recruiting NCT03469310 Phase 4 Acetaminophen 500Mg Cap;Tylenol #3 Oral Tablet;Tramadol
41 Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens Recruiting NCT03298945 Phase 4 Miralax-Gatorade Prep;Golytely
42 The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity Recruiting NCT02102243 Phase 4 DEFINITY® infusion;Human Recombinant Regular Insulin infusion;Dextrose infusion
43 Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding Active, not recruiting NCT02032784 Phase 4 octreotide
44 Phase IV, Open-label, Multi-center, Single-arm Study of the Safety and Efficacy of Everolimus (Afinitor) in Adult Patients With Local Advanced or Metastatic, Well Differentiated Progressive Pancreatic Neuroendocrine Tumors (pNET) in China. Active, not recruiting NCT02842749 Phase 4 everolimus
45 A Multicentre Randomized Parallel Group Phase IV Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen. Active, not recruiting NCT03742232 Phase 4 PEG3350;Macrogol 4000
46 Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy Not yet recruiting NCT03352700 Phase 4 3L PEG;3L PEG+Dyclonine Hydrochloride Mucilage
47 Comparison of the Efficacy and Tolerability Between 3-L and 4-L Polyethylene Glycol in Bowel Preparation Not yet recruiting NCT03356015 Phase 4 4L Polyethylene Glycol;3L Polyethylene Glycol
48 A Randomized Controlled Trial of Tailored Bowel Preparation Based on A Predictive Model for Inadequate Bowel Preparation Not yet recruiting NCT03704571 Phase 4 Polyethylene Glycol
49 Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas Suspended NCT01023984 Phase 4
50 A Pilot Study of Pre- and Post-operative Somatuline Depot Therapy in Acromegalic Patients Treated by Endonasal Endoscopic Surgery: Impact on Early Remission Rates and Perioperative Morbidity Terminated NCT01861717 Phase 4 lanreotide

Search NIH Clinical Center for Papillary Adenoma

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Octreotide
Octreotide Acetate

Cochrane evidence based reviews: adenoma

Genetic Tests for Papillary Adenoma

Anatomical Context for Papillary Adenoma

MalaCards organs/tissues related to Papillary Adenoma:

41
Colon, Pituitary, Testes, Prostate, Thyroid, Liver, Pancreas

Publications for Papillary Adenoma

Articles related to Papillary Adenoma:

(show top 50) (show all 291)
# Title Authors PMID Year
1
[Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands]. 38
31285043 2019
2
Allosteric and ATP-Competitive Inhibitors of mTOR Effectively Suppress Tumor Progression-Associated Epithelial-Mesenchymal Transition in the Kidneys of Tsc2+/- Mice. 38
31207499 2019
3
Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells. 38
31381885 2019
4
Validation of Region of Interest Measurements for the Objective Assessment of Post-Contrast Enhancement of Renal Lesions on MRI. 38
31365281 2019
5
Rare Huge Tubular Papillary Adenoma on the Buttock Demonstrated by Magnetic Resonance Imaging (MRI). 38
31406100 2019
6
Malignant rhabdoid tumor of the musk gland and systemic T-cell lymphoma in a masked palm civet (Paguma larvata). 38
31092741 2019
7
Alterations of the bile microbiome in primary sclerosing cholangitis. 38
31243055 2019
8
A case of intraductal papillary neoplasm of the bile duct that developed 38 years after choledochoduodenostomy with invasive adenocarcinoma and lymph node metastasis. 38
31175474 2019
9
Surgical Resection of Endobronchial Glandular Papilloma. 38
30309633 2019
10
[Clinicopathological analysis of pulmonary mixed squamous cell and glandular papilloma]. 38
30955271 2019
11
A 17-year-old woman with a solitary, mixed squamous cell and glandular papilloma of the bronchus. 38
30519472 2019
12
Mixed squamous cell and glandular papilloma of the lung: A case report of a novel mutation in the BRAF gene and coexistent HPV infection, possible relationship to ciliated muconodular papillary tumor. 38
30664316 2019
13
Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study. 38
30418186 2019
14
Coexistence of glandular papilloma and sclerosing pneumocytoma in the bronchiole. 38
29696743 2018
15
AMACR Positive Papillary Renal Adenomatosis and Multifocal Papillary Carcinoma in End Stage Renal Disease. 38
29887709 2018
16
MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma. 38
29549624 2018
17
A unique case of a huge mixed squamous cell and glandular papilloma of non-endobronchial origin with a peripheral growth. 38
29977775 2018
18
Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma. 38
28033156 2017
19
Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types. 38
28923625 2017
20
Pulmonary Papillary Adenoma: Report of Two Cases. 38
29017679 2017
21
GLUT-1 expression of pulmonary mixed squamous cell and glandular papilloma may be associated with high SUVmax on fluorodeoxyglucose-positron emission tomography. 38
28590021 2017
22
Expression of p16Ink4a in mixed squamous cell and glandular papilloma of the lung. 38
28470939 2017
23
Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct. 38
28415560 2017
24
Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma. 38
28233444 2017
25
Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report. 38
28763696 2017
26
A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest. 38
28502963 2017
27
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. 38
26935559 2016
28
Cytomorphologic findings and differential diagnosis of pulmonary papillary adenoma: A case report and literature review. 38
27040894 2016
29
Mixed squamous cell and glandular papilloma of the lung resembling early adenocarcinoma: A case report. 38
27141302 2016
30
Papillary adenoma arising from an extensive biliary low-grade intraepithelial neoplasia. 38
26477935 2016
31
Papillary adenoma of the common bile duct: Infrequent pathology, novel endoscopic resolution, rare complication. A case report. 38
26993161 2016
32
Ciliated muconodular papillary tumor: a solitary peripheral lung nodule in a teenage girl. 38
26826405 2016
33
Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder. 38
26643927 2016
34
GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms. 38
26595821 2015
35
[Mixed squamous cell and glandular papilloma: a report of 4 cases and review of literature]. 38
26888391 2015
36
A rare cause of chronic cough: solitary glandular papilloma of the lung. 38
24796508 2015
37
Pulmonary papillary adenoma presenting in central portion: a case report. 38
26474555 2015
38
[BILE DUCT PROBLEMS - ENDOSCOPIC SOLUTIONS]. 38
26480620 2015
39
Technical improvement using ultra-slim gastroscopes for direct peroral cholangioscopy: analysis of the initial learning phase. 38
25307938 2015
40
Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem. 38
25992997 2015
41
Solitary endobronchial papillomas with false impression of malignant transformation: report of two cases and review of the literature. 38
26339442 2015
42
Renal myopericytoma: a clinicopathologic study of six cases and review of the literature. 38
26191123 2015
43
Local excision of papillary adenoma in patients with high surgical risk for pancreaticoduodenectomy. 38
25626947 2014
44
Microscopic small clear cell papillary lesion of the kidney with long-term hemodialysis patient: is this clear cell papillary adenoma? 38
25622340 2014
45
Recent classification of renal epithelial tumors. 38
23529139 2014
46
Rapidly growing glandular papilloma associated with mucus production: a case report. 38
24886616 2014
47
Solitary glandular papilloma of the peripheral lung: a report of two cases. 38
24885310 2014
48
Mixed squamous cell and glandular papilloma of the lung in a 64-year-old woman. 38
24570869 2014
49
A rare case of pulmonary papillary adenoma in old aged woman: a brief case report. 38
24627699 2014
50
A young lady with post-partum jaundice and right upper quadrant lump abdomen: an unusual etiology. 38
24714559 2014

Variations for Papillary Adenoma

Expression for Papillary Adenoma

Search GEO for disease gene expression data for Papillary Adenoma.

Pathways for Papillary Adenoma

Pathways related to Papillary Adenoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.82 VIM KRT7 KRT5
2
Show member pathways
11.59 KRT7 KRT5 KRT3
3
Show member pathways
10.83 VIM KRT7 KRT5

GO Terms for Papillary Adenoma

Cellular components related to Papillary Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.55 VIM NAPSA KRT7 KRT5 KRT3
2 keratin filament GO:0045095 9.13 KRT7 KRT5 KRT3
3 intermediate filament GO:0005882 8.92 VIM KRT7 KRT5 KRT3

Biological processes related to Papillary Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.13 KRT7 KRT5 KRT3
2 cornification GO:0070268 8.8 KRT7 KRT5 KRT3

Molecular functions related to Papillary Adenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 scaffold protein binding GO:0097110 8.96 VIM KRT5
2 structural molecule activity GO:0005198 8.32 VIM

Sources for Papillary Adenoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....